The friendly acquisition of Syngenta by ChemChina is now formally offered to the shareholders at 465 US$ per ordinary share plus a special dividend of 5 Swiss Francs. As no opposition has been voiced since the deal was announced, Read more
In addition to the previous blog post, I put here a link to a paper that was written in 2010 about the expansion of companies from emerging countries expanding in global markets:
http://mr-int.ch/images/documents/global_emerging_companies.pdf
Was I already prophet in my own country?…
Today Syngenta announced that, for 43 billion dollars, it will be acquired by ChemChina.
Why is it bad news ?
While agribusiness is in a low phase of its cycle, the Syngenta situation is far from being resolved. On one hand, financial results are not at the height of [too greedy?] expectations of shareholders, and on the strategic side Read more
Once again, discussions are on-going about a possible acquisition of Syngenta, now by ChemChina or whoever else, or a merger with nobody knows who.
When this company was created as a merged spin-off of the agricultural businesses from AstraZeneca Read more
Something in relation with my business relations (www.mr-int.ch).
Every decade or so, any industry seems to have to undertake a fundamental shake-out. This is now the case of the pesticides-cum-seeds sector. Large strategic, financial, regulatory, and political Read more